QuiaPEG Pharmaceuticals Holding AB - ESG Rating & Company Profile powered by AI
If you are employed by QuiaPEG Pharmaceuticals Holding AB and you would like to licence your Sustainability aseessment, please get in touch. Scroll down to the end of the page for potential risks for QuiaPEG Pharmaceuticals Holding AB based on industry, location and size. The Disclosure rating covers 17 UN SDGs including: 'Good Health & Wellbeing', 'Responsible Production & Consumption' and 'Life below Water'.
QuiaPEG Pharmaceuticals Holding AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 2.7, social score of 4.0 and governance score of 5.3.
4.0
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
989 | Tricida Inc | 4.1 | High |
1004 | QuiaPEG Pharmaceuticals Holding AB | 4.0 | High |
1004 | Can B Corp | 4.0 | High |
1004 | CLS Holdings USA Inc | 4.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does QuiaPEG Pharmaceuticals Holding AB have an accelerator or VC vehicle to help deliver innovation?
Does QuiaPEG Pharmaceuticals Holding AB disclose current and historical energy intensity?
Does QuiaPEG Pharmaceuticals Holding AB report the average age of the workforce?
Does QuiaPEG Pharmaceuticals Holding AB reference operational or capital allocation in relation to climate change?
Does QuiaPEG Pharmaceuticals Holding AB disclose its ethnicity pay gap?
Does QuiaPEG Pharmaceuticals Holding AB disclose cybersecurity risks?
Does QuiaPEG Pharmaceuticals Holding AB offer flexible work?
Does QuiaPEG Pharmaceuticals Holding AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does QuiaPEG Pharmaceuticals Holding AB disclose the number of employees in R&D functions?
Does QuiaPEG Pharmaceuticals Holding AB conduct supply chain audits?
Does QuiaPEG Pharmaceuticals Holding AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does QuiaPEG Pharmaceuticals Holding AB conduct 360 degree staff reviews?
Does QuiaPEG Pharmaceuticals Holding AB disclose the individual responsible for D&I?
Does QuiaPEG Pharmaceuticals Holding AB disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does QuiaPEG Pharmaceuticals Holding AB disclose current and / or historical scope 2 emissions?
Does QuiaPEG Pharmaceuticals Holding AB disclose water use targets?
Does QuiaPEG Pharmaceuticals Holding AB have careers partnerships with academic institutions?
Did QuiaPEG Pharmaceuticals Holding AB have a product recall in the last two years?
Does QuiaPEG Pharmaceuticals Holding AB disclose incidents of discrimination?
Does QuiaPEG Pharmaceuticals Holding AB allow for Work Councils/Collective Agreements to be formed?
Has QuiaPEG Pharmaceuticals Holding AB issued a profit warning in the past 24 months?
Does QuiaPEG Pharmaceuticals Holding AB disclose parental leave metrics?
Does QuiaPEG Pharmaceuticals Holding AB disclose climate scenario or pathway analysis?
Does QuiaPEG Pharmaceuticals Holding AB disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does QuiaPEG Pharmaceuticals Holding AB disclose the pay ratio of women to men?
Does QuiaPEG Pharmaceuticals Holding AB support suppliers with sustainability related research and development?
Does QuiaPEG Pharmaceuticals Holding AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does QuiaPEG Pharmaceuticals Holding AB reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is QuiaPEG Pharmaceuticals Holding AB involved in embryonic stem cell research?
Does QuiaPEG Pharmaceuticals Holding AB disclose GHG and Air Emissions intensity?
Does QuiaPEG Pharmaceuticals Holding AB disclose its waste policy?
Does QuiaPEG Pharmaceuticals Holding AB report according to TCFD requirements?
Does QuiaPEG Pharmaceuticals Holding AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does QuiaPEG Pharmaceuticals Holding AB disclose energy use targets?
Does QuiaPEG Pharmaceuticals Holding AB disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does QuiaPEG Pharmaceuticals Holding AB have a policy relating to cyber security?
Have a different question?
Potential Risks for QuiaPEG Pharmaceuticals Holding AB
These potential risks are based on the size, segment and geographies of the company.
QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. The company has strategic collaboration with Cobra Biologics AB for the refinement of biopharmaceutical products. The company was formerly known as Oligovation AB and changed its name to QuiaPEG Pharmaceuticals Holding AB (publ). QuiaPEG Pharmaceuticals Holding AB (publ) was founded in 2012 and is headquartered in Solna, Sweden.